GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (ISX:MERK) » Definitions » Other Operating Expense

PT Merck Tbk (ISX:MERK) Other Operating Expense : Rp105,906 Mil (TTM As of Mar. 2025)


View and export this data going back to 1981. Start your Free Trial

What is PT Merck Tbk Other Operating Expense?

PT Merck Tbk's Other Operating Expense for the three months ended in Mar. 2025 was Rp20,205 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was Rp105,906 Mil.

PT Merck Tbk's quarterly Other Operating Expense increased from Sep. 2024 (Rp22,018 Mil) to Dec. 2024 (Rp43,157 Mil) but then declined from Dec. 2024 (Rp43,157 Mil) to Mar. 2025 (Rp20,205 Mil).

PT Merck Tbk's annual Other Operating Expense increased from Dec. 2022 (Rp95,789 Mil) to Dec. 2023 (Rp105,158 Mil) and increased from Dec. 2023 (Rp105,158 Mil) to Dec. 2024 (Rp111,461 Mil).


PT Merck Tbk Other Operating Expense Historical Data

The historical data trend for PT Merck Tbk's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk Other Operating Expense Chart

PT Merck Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101,795.96 119,990.77 95,788.54 105,158.14 111,461.04

PT Merck Tbk Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25,759.96 20,526.10 22,018.29 43,156.70 20,205.22

PT Merck Tbk Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp105,906 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Merck Tbk Other Operating Expense Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Merck Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines for colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes, as well as thyroid disorders such as hypothyroidism.

PT Merck Tbk Headlines

No Headlines